1. Home
  2. REBN vs ADVB Comparison

REBN vs ADVB Comparison

Compare REBN & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reborn Coffee Inc.

REBN

Reborn Coffee Inc.

HOLD

Current Price

$1.80

Market Cap

8.7M

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$0.37

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REBN
ADVB
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
8.4M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
REBN
ADVB
Price
$1.80
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
134.0K
66.5K
Earning Date
11-19-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,663,303.00
N/A
Revenue This Year
$335.98
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.09
N/A
52 Week Low
$1.36
$0.28
52 Week High
$8.30
$4.10

Technical Indicators

Market Signals
Indicator
REBN
ADVB
Relative Strength Index (RSI) 55.86 43.92
Support Level $1.50 $0.29
Resistance Level $1.97 $0.36
Average True Range (ATR) 0.16 0.03
MACD 0.03 0.00
Stochastic Oscillator 66.06 48.83

Price Performance

Historical Comparison
REBN
ADVB

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: